These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9883213)

  • 1. Metallic ureteric stents: early experience.
    Pandian SS; Hussey JK; McClinton S
    Br J Urol; 1998 Dec; 82(6):791-7. PubMed ID: 9883213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
    Flam T; Géraud M; Zerbib M; Debré B; Steg A
    Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with the resonance metallic stent for antegrade ureteric stenting.
    Wah TM; Irving HC; Cartledge J
    Cardiovasc Intervent Radiol; 2007; 30(4):705-10. PubMed ID: 17508238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative urinary diversion for pelvic malignancy.
    Brin EN; Schiff M; Weiss RM
    J Urol; 1975 May; 113(5):619-22. PubMed ID: 47918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of antegrade stenting for lower ureteric obstruction.
    Jenkins CN; Marcus AJ
    J R Soc Med; 1995 Aug; 88(8):446-9. PubMed ID: 7562827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallic stents for malignant and benign ureteric obstruction.
    Wakui M; Takeuchi S; Isioka J; Iwabuchi K; Morimoto S
    BJU Int; 2000 Feb; 85(3):227-32. PubMed ID: 10671873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions.
    Wijayarathna S; Suvendran S; Ishak M; Weligamage A; Epa A; Munasinghe S; Abeygunaskera AM
    Ceylon Med J; 2014 Dec; 59(4):124-7. PubMed ID: 25556408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of ureteric obstruction secondary to malignant pelvic disease.
    Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
    Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results.
    Tekin MI; Aytekin C; Aygün C; PeSkircioğlu L; Boyvat F; Ozkardeş H
    Urology; 2001 Dec; 58(6):919-23. PubMed ID: 11744459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of metallic stents to bypass ureteral strictures secondary to metastatic prostate cancer: experience with 8 patients.
    López-Martínez RA; Singireddy S; Lang EK
    J Urol; 1997 Jul; 158(1):50-3. PubMed ID: 9186321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy palliation in malignancy-associated ureteral obstruction.
    Ampil FL
    Radiat Med; 1989; 7(6):282-6. PubMed ID: 2483756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thermo-expandable metallic ureteric stent: an 11-year follow-up.
    Agrawal S; Brown CT; Bellamy EA; Kulkarni R
    BJU Int; 2009 Feb; 103(3):372-6. PubMed ID: 18778347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Internal urinary diversion in pelvic cancers and quality of life. Value of double "J" endoprosthesis].
    Giannakopoulos X; Gartzios A; Giannakis D; Tsamboulas K; Kotoulas K
    J Urol (Paris); 1995; 101(5-6):221-7. PubMed ID: 8761875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents.
    Rotariu P; Yohannes P; Alexianu M; Rosner D; Lee BR; Lucan M; Smith AD
    J Endourol; 2001 Dec; 15(10):979-83. PubMed ID: 11789979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic bilateral cutaneous ureterostomy for palliation of ureteral obstruction caused by advanced pelvic cancer.
    Puppo P; Perachino M; Ricciotti G; Bozzo W
    J Endourol; 1994 Dec; 8(6):425-8. PubMed ID: 7535620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of metallic stents for malignant ureteral obstruction in advanced cervical carcinoma.
    Lang EK; Winer AG; Abbey-Mensah G; Anne R; Allaei A; Friedman F; Thomas R; La Nasa J; Davis R
    J Endourol; 2013 May; 27(5):646-51. PubMed ID: 23199302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent-change therapy in advanced malignancies with ureteral obstruction.
    Rosenberg BH; Bianco FJ; Wood DP; Triest JA
    J Endourol; 2005; 19(1):63-7. PubMed ID: 15735386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.
    Patel C; Loughran D; Jones R; Abdulmajed M; Shergill I
    BMC Urol; 2017 Mar; 17(1):16. PubMed ID: 28283031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detour extra-anatomic stent--a permanent solution for benign and malignant ureteric obstruction?
    Lloyd SN; Tirukonda P; Biyani CS; Wah TM; Irving HC
    Eur Urol; 2007 Jul; 52(1):193-8. PubMed ID: 17126477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.